Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study.
Ahmet BiliciMukremin UysalSerkan MenekseSemih AkinFatih YildizMerve TuranSema Sezgin GoksuIsmail BeypinarTeoman SakalarMustafa DeğirmenciDilek ErdemGul BasaranOmer Fatih OlmezNilufer AvciDeniz TuralAbdullah SakinSema TurkerAtakan DemirSuleyman TemizMuhammed Ali KaplanMutlu DoganOzgur TanriverdiIrem BilgetekinHavva Yesil CinkirOzgur AcikgozSemra PaydaşRuchan UsluSerdar TurhalPublished in: Cancer investigation (2021)
We confirmed the favorable efficacy and safety profile of EVE + EXE for HR+, HER - MBC patients.